Licensing deals

Tiny green sprout growing from soil
Biotech

Chiesi fertilizes Arbor's gene therapy with $2B biobucks deal

Chiesi is shelling out $115 million upfront to develop and commercialize ABO-101, a gene therapy for primary hyperoxaluria type 1.
Darren Incorvaia Oct 6, 2025 7:00am
100 dollar bills scattered in the air money inflation concept

AbbVie flags $2.7B R&D hit to brace investors for lower profit

Oct 6, 2025 3:27am
A ballpoint pen rests on top of a stack of documents ready for signing

Kyorin pens $105M pact for Japan rights to Hinge's lupus drug

Oct 1, 2025 6:40am
A close-up view of a jigsaw puzzle with a missing piece

Novo Holdings-backed biotech raises $205M to fill gout care gap

Sep 30, 2025 8:00am
Glowing puzzle piece fitting into puzzle

Gilead pumps up virology pipeline with drug transporter deal

Sep 29, 2025 10:35am
HPE conf

US biotechs thinking twice about licensing drugs to Europe

Sep 26, 2025 8:09am